Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

Cristina Maria De Fátima Guastini

首页> 外文期刊>Brazilian Journal of Infectious Diseases >Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

【24h】

Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

机译：拉米夫定治疗慢性乙型肝炎伴发急性胰腺炎

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.

机译：高淀粉血症是拉米夫定使用期间的常见并发症。我们报告了拉米夫定治疗后发生的胰腺炎病例。考虑到这次检查的费用和进一步的并发症，主要在最初的几周内，讨论了在拉米夫定治疗期间仔细监测淀粉酶水平的问题。

著录项

来源
《Brazilian Journal of Infectious Diseases》 |2008年第4期|共1页
作者
Cristina Maria De Fátima Guastini;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B. [J] . Tsubota A, Arase Y, Suzuki F, Journal of Medical Virology . 2004,第1期

机译：长期拉米夫定治疗乙型肝炎e抗原阳性的慢性乙型肝炎时，严重的肝病急性加重可能减少或延迟YMDD基序突变体的出现。
2. Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study. [J] . Akuta N, Tsubota A, Suzuki F, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2003,第1期

机译：拉米夫定单药治疗慢性乙型肝炎严重急性加重的长期预后：YMDD基序突变的出现和突破性肝炎的风险-一项开放队列研究。
3. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy. [J] . Kim HJ, Park JH, Park DI, Journal of gastroenterology and hepatology . 2010,第8期

机译：拉米夫定耐药的慢性乙型肝炎的抢救治疗：恩替卡韦1.0 mg单一疗法，阿德福韦单一疗法和阿德福韦附加拉米夫定联合疗法之间的比较。
4. Adefovir dipivoxil for the treatment of chronic hepatitis B infection and in vitro evaluation of hte cross-resistance profiles of lamivudine,famciclovir and adefovir [C] . X Xiong, A Murray, H Yang, Second workshop related to HIV/AIDS in China . 1999

机译：阿德福韦酯对慢性乙型肝炎感染的治疗以及拉米夫定，泛昔洛韦和阿德福韦的交叉耐药性的体外评估
5. Immune Responses During Resolution of Acute Hepatitis B in Woodchucks and Their Modulation for Treatment of Chronic Hepatitis B [D] . Suresh, Manasa. 2020

机译：桃毛急性乙型肝炎分辨率的免疫反应及其治疗慢性乙型肝炎
6. Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B [O] . Jeong Han Kim, Hee Won Moon, Soon Young Ko, 2014

机译：治疗后6个月的乙型肝炎表面抗原水平可以预测拉米夫定-阿德福韦联合治疗对耐拉米夫定的慢性乙型肝炎患者的疗效
7. Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis [O] . TUON, Felipe Francisco, GUASTINI, Cristina Maria de Fátima, BOULOS, Maria Ivete Castro 2008

机译：拉米夫定治疗慢性乙型肝炎伴发急性胰腺炎

Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

摘要

著录项

相似文献

相关主题

期刊订阅